The intervention effect of rosiglitozone in ovarian fibrosis of PCOS rats

Biomedical and Environmental Sciences

Volumn 25, Issue 1, 2012, Pages 46-52

  Miao, Zhu Lin ^a   Guo, Liang ^b   Wang, Yong Xia ^a   Cui, Rong ^a   Yang, Ning ^a   Huang, Mi Qiong ^a   Qin, Wei Bing ^a   Chen, Jin ^a   Li, Hong Mei ^a   Wang, Zi Neng ^c   Wei, Xiang Cai ^a  

^a Department of Reproductive Immunology and Endocrinology   (China)

^b SOUTH CHINA NORMAL UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

Author keywords

Connective tissue growth factor; Polycystic ovary syndrome; Rosiglitozone; Transforming growth factor 1

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; CONNECTIVE TISSUE GROWTH FACTOR; CTGF PROTEIN, RAT; ROSIGLITAZONE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BLOOD; FEMALE; FIBROSIS; METABOLISM; OVARY; OVARY POLYCYSTIC DISEASE; PATHOLOGY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; CONNECTIVE TISSUE GROWTH FACTOR; FEMALE; FIBROSIS; HYPOGLYCEMIC AGENTS; OVARY; POLYCYSTIC OVARY SYNDROME; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLIDINEDIONES; TRANSFORMING GROWTH FACTOR BETA;

RATTUS;

EID: 84863340975     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.3967/0895-3988.2012.01.007     Document Type: Article

References (20)

1. DA Dumesic, DH Abbott Implications of polycystic ovary syndrome on oocyte development Semin Reprod Med 26 2008 53 61
2. F Verrecchia, A Mauviel Transforming growth factor-beta and fibrosis World J Gastroenterol 13 2007 3056 3062
3. L Yang, CC Chan, OS Kwon et al. Regulation of peroxisome proliferators activated receptor gamma in liver fibrosis Am J Physiol Gastrointest Liver Physiol 291 2006 G902 G911
4. O Seda, L Sedova, O Oliyarnyk et al. Pharmacogenomics of metabolic effects of rosiglitazone Pharmacogenomics 9 2008 141 155 (Pubitemid 351566939)
5. G Svegliati-Baroni, S De Minicis, M Marzioni Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition Liver Int 28 2008 1052 1064
6. B Crestani, S Marchand-Adam, A Fabre et al. Mechanisms in pulmonary fibrosis Rev Prat 57 2007 2222 2226
7. M Ouzounian, DS Lee, PP Liu Diastolic heart failure: mechanisms and controversies Nat Clin Pract Cardiovasc Med 5 2008 375 386 (Pubitemid 351935571)
8. P Boor, K Sebeková, T Ostendorf et al. Treatment targets in renal fibrosis Nephrol Dial Transplant 22 2007 3391 3407 (Pubitemid 350212482)
9. K Shimizu Mechanisms of pancreatic fibrosis and applications to the treatment of chronic pancreatitis J Gastroenterol 43 2008 823 832
10. EM Carnevale The mare model for follicular maturation and reproductive aging in the woman Theriogenology 69 1 2008 23 30 (Pubitemid 350166506)
11. RJ Rodgers, HF Irving-rodgers, DL Russell Extracellular matrix of the developing ovarian follicle Reproduction 126 2003 415 424 (Pubitemid 37369602)
12. S Goldman, E Shalev MMPS and TIMPS in ovarian physiology and pathophysiology Front Biosci 9 2004 2474 2483
13. NN Singh, DP Ramji The role of transforming growth factor-beta in atherosclerosis Cytokine Growth Factor Rev 17 2006 487 499 (Pubitemid 44793117)
14. JJ Song, R Aswad, RA Kanaan et al. Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF-beta1 to induce mesenchymal cell condensation J Cell Physio 1210 2007 398 410 (Pubitemid 44956885)
15. B Liu, YM Guan, JH Zheng Elevated serum levels of matrix metalloproteinase-2 in women with polycystic ovarian syndrome Int J Gynaecol Obstet 96 2007 204 205 (Pubitemid 46281913)
16. PD Home, SJ Pocock, IH Becken et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomized, open label trial Lancet 373 2009 2125 2135
17. A Majuri, M Santaniemi, K Rautio et al. Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo controlled study Eur J Endocrinol 156 2008 263 269 (Pubitemid 46554522)
18. DM Nathan, MD Kahn Thiazolidinediones for initial treatment of type 2 diabetes New Engl J med 355 2006 2477 2480 (Pubitemid 44903753)
19. Z Omer, S Cetinkalp, M Akyildiz et al. Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease Eur J Gastroenterol Hepatol 22 2010 18 23
20. SE Nissen, Wolskik Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med 356 2007 2457 2471 (Pubitemid 46919772)